TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT07489885: A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis

Sponsor: InventisBio Co., Ltd · Phase: PHASE2 · Area: DERMATOLOGY_AESTHETIC · Target Enrollment: 75 pts

Competing Trials Overlap

13 Active Trials

Excess Burn Exposure

$1,831,800

Rescue Site Savings

+$1,212,600

Unlock Full NCT07489885 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07489885 Rescue Dossier →